Cart
sales@molnova.com
Indomethacin heptyl ester
CAS No. 282728-47-6
Indomethacin heptyl ester( —— )
Catalog No. M27504 CAS No. 282728-47-6
Indomethacin heptyl ester is a non-selective inhibitor of both COX-1 and COX-2
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 202 | In Stock |
|
| 2MG | 56 | In Stock |
|
| 5MG | 117 | In Stock |
|
| 10MG | 202 | In Stock |
|
| 25MG | 464 | In Stock |
|
| 50MG | 662 | In Stock |
|
| 100MG | 918 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1841 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIndomethacin heptyl ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionIndomethacin heptyl ester is a non-selective inhibitor of both COX-1 and COX-2
-
DescriptionIndomethacin heptyl ester is a non-selective inhibitor of both COX-1 and COX-2
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorAChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number282728-47-6
-
Formula Weight455.97
-
Molecular FormulaC26H30ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCCCCCC)CC1=C(C)N(C(C2=CC=C(Cl)C=C2)=O)C3=C1C=C(OC)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yun KJ, et al. Quaternary alkaloid, pseudocoptisine isolated from tubers of Corydalis turtschaninovi inhibits LPS-induced nitric oxide, PGE(2), and pro-inflammatory cytokines production via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells. Int Immunopharmacol. 2009;9(11):1323-1331.
molnova catalog
related products
-
Zileuton
Zileuton (A-64077) is a selective and potent 5-LO inhibitor, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation.
-
Seratrodast
Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
-
Bufexamac
Bufexamac is a COX inhibitor for IFN-α release.
